KATY COOL: Open Payments
NPI 1972201580 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,009 in 62 payments from 18 companies in 2025. Trend: 2023 $1,245 · 2024 $1,395 · 2025 $3,009
Food & beverage: $1,369Travel & lodging: $1,198Education: $441
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $1,637 |
| Astellas Pharma US Inc | 11 | $484 |
| Sumitomo Pharma America, Inc. | 12 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Janssen Biotech, Inc. | 6 | $115 |
| SEAGEN INC. | 1 | $85 |
| UROGEN PHARMA, INC. | 2 | $74 |
| Verity Pharmaceuticals Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Teleflex LLC | 1 | $30 |
Products named: Axonics, Xtandi, ORGOVYX, Nubeqa, ERLEADA, GEMTESA, JELMYTO, PLUVICTO.
Industry payments across IN — which companies pay providers there.
